Cargando…

Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetes

BACKGROUND: Fewer circulating endothelial progenitor cells (EPCs) and increased plasma (C-term) stromal cell-derived factor 1α (SDF-1α), a substrate of DPP-4, are biomarkers, and perhaps mediators, of cardiovascular risk and mortality. Short-term/acute treatment with DPP-4 inhibitors improve EPC bio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dei Cas, Alessandra, Spigoni, Valentina, Cito, Monia, Aldigeri, Raffaella, Ridolfi, Valentina, Marchesi, Elisabetta, Marina, Michela, Derlindati, Eleonora, Aloe, Rosalia, Bonadonna, Riccardo C., Zavaroni, Ivana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324295/ https://www.ncbi.nlm.nih.gov/pubmed/28231835 http://dx.doi.org/10.1186/s12933-017-0503-0

Ejemplares similares

Transcriptomic Analysis of Human Polarized Macrophages: More than One Role of Alternative Activation?
por: Derlindati, Eleonora, et al.
Publicado: (2015)

Effects of a New Nutraceutical Formulation (Berberine, Red Yeast Rice and Chitosan) on Non-HDL Cholesterol Levels in Individuals with Dyslipidemia: Results from a Randomized, Double Blind, Placebo-Controlled Study
por: Spigoni, Valentina, et al.
Publicado: (2017)

Pioglitazone Improves In Vitro Viability and Function of Endothelial Progenitor Cells from Individuals with Impaired Glucose Tolerance
por: Spigoni, Valentina, et al.
Publicado: (2012)

Correction: Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects
por: Matone, Alice, et al.
Publicado: (2019)

Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects
por: Matone, Alice, et al.
Publicado: (2017)

Effects of TiO(2) and Co(3)O(4) Nanoparticles on Circulating Angiogenic Cells
por: Spigoni, Valentina, et al.
Publicado: (2015)

Effects on Nitric Oxide Production of Urolithins, Gut-Derived Ellagitannin Metabolites, in Human Aortic Endothelial Cells
por: Spigoni, Valentina, et al.
Publicado: (2016)

Empagliflozin does not reverse lipotoxicity-induced impairment in human myeloid angiogenic cell bioenergetics
por: Cinquegrani, Gloria, et al.
Publicado: (2022)

SARS-CoV-2 Spike protein is not pro-inflammatory in human primary macrophages: endotoxin contamination and lack of protein glycosylation as possible confounders
por: Cinquegrani, Gloria, et al.
Publicado: (2022)

Bioavailability of Bergamot (Citrus bergamia) Flavanones and Biological Activity of Their Circulating Metabolites in Human Pro-Angiogenic Cells
por: Spigoni, Valentina, et al.
Publicado: (2017)

Sodium-glucose cotransporter 2 inhibitors antagonize lipotoxicity in human myeloid angiogenic cells and ADP-dependent activation in human platelets: potential relevance to prevention of cardiovascular events
por: Spigoni, Valentina, et al.
Publicado: (2020)

Development of an Oral (Poly)Phenol Challenge Test (Opct) to Identify Aggregate Metabotypes for Dietary (Poly)Phenols and Their Drivers: A Study Protocol
por: Mena, Pedro, et al.
Publicado: (2022)

Randomized Study Comparing Vildagliptin vs Glibenclamide on Glucose Variability and Endothelial Function in Patients with Type 2 Diabetes Mellitus and Hypertension
por: Cosenso-Martin, Luciana Neves, et al.
Publicado: (2020)

Performance and anthropometric characteristics of Elite Rugby Players
por: Pasin, Federico, et al.
Publicado: (2017)

Activation of G protein-coupled receptors by ketone bodies: Clinical implication of the ketogenic diet in metabolic disorders
por: Spigoni, Valentina, et al.
Publicado: (2022)

Twelve-week randomized study to compare the effect of vildagliptin vs. glibenclamide both added-on to metformin on endothelium function in patients with type 2 diabetes and hypertension
por: Cosenso-Martin, Luciana Neves, et al.
Publicado: (2015)

SAT-141 Effect of Vildagliptin versus Glibenclamide on Glycemic Variability and Endothelial Function in Individuals with Type 2 Diabetes and Hypertension: A Randomized Controlled Trial
por: Cosenso-Martin, Luciana, et al.
Publicado: (2019)

Effects of vildagliptin compared with glibenclamide on glucose variability after a submaximal exercise test in patients with type 2 diabetes: study protocol for a randomized controlled trial, DIABEX VILDA
por: Fofonka, Aline, et al.
Publicado: (2014)

Ten Years of Vildagliptin
por: Del Prato, Stefano
Publicado: (2017)

Surfing the Vildagliptin Tsunami
por: Balachandran, Karthik
Publicado: (2020)

Claimed Effects, Outcome Variables and Methods of Measurement for Health Claims on Foods Related to Vision Proposed Under Regulation (EC) 1924/2006
por: Martini, Daniela, et al.
Publicado: (2018)

Data on vildagliptin and vildagliptin plus metformin combination in type-2 diabetes mellitus management
por: Das, Sambit, et al.
Publicado: (2021)

Interaction of Herbs and Glibenclamide: A Review
por: Rai, Amita, et al.
Publicado: (2012)

Glibenclamide for the Treatment of Ischemic and Hemorrhagic Stroke
por: Caffes, Nicholas, et al.
Publicado: (2015)

Glibenclamide Prevents Diabetes in NOD Mice
por: Lamprianou, Smaragda, et al.
Publicado: (2016)

Glibenclamide for the Treatment of Acute CNS Injury
por: Kurland, David B., et al.
Publicado: (2013)

Effect of Vildagliptin on Hepatic Steatosis
por: Macauley, Mavin, et al.
Publicado: (2015)

Claimed Effects, Outcome Variables and Methods of Measurement for Health Claims Proposed Under European Community Regulation 1924/2006 in the Framework of Maintenance of Skin Function
por: Martini, Daniela, et al.
Publicado: (2017)

Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment
por: Lukashevich, Valentina, et al.
Publicado: (2013)

Mucoadhesive buccal films of glibenclamide: Development and evaluation
por: Muzib, Y Indira, et al.
Publicado: (2011)

Glibenclamide dose response in patients with septic shock
por: Morelli, A, et al.
Publicado: (2007)

Pharmacokinetic interaction of curcumin and glibenclamide in diabetic rats
por: Devi, P. R. Sakunthala, et al.
Publicado: (2015)

Glibenclamide: A second wind for refractory hyperkalemia
por: Senthilkumaran, Subramanian, et al.
Publicado: (2014)

Mild acute pancreatitis with vildagliptin use
por: Saraogi, Ravikant, et al.
Publicado: (2012)

Vasculoprotective Effects of Vildagliptin. Focus on Atherogenesis
por: Wiciński, Michał, et al.
Publicado: (2020)

Effect of race and ethnicity on vildagliptin efficacy: A pooled analysis of phase II and III studies
por: Kozlovski, Plamen, et al.
Publicado: (2017)

Effect of glibenclamide on antinociceptive effects of antidepressants of different classes
por: Hajhashemi, Valiollah, et al.
Publicado: (2011)

Reversal of experimentally induced seizure activity in mice by glibenclamide
por: Pithadia, Anand B., et al.
Publicado: (2013)

Assessment of In Vivo and In Vitro Genotoxicity of Glibenclamide in Eukaryotic Cells
por: de Sant’Anna, Juliane Rocha, et al.
Publicado: (2015)

Anthelminthic activity of glibenclamide on secondary cystic echinococcosis in mice
por: Loos, Julia A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ohhp0qeepo31o5ddhfijob5r1m